Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maaike E Ressing

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Virology|December 17, 2010
The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus VaricellovirusMarieke C Verweij, Andrea D Lipinska, Danijela Koppers-Lalic, et al.
Plos Pathogens|March 4, 2014
Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signalingMichiel van Gent, Steven G E Braem, Annemieke de Jong, et al.
Cancer Gene Therapy|November 9, 2023
Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8<sup>+</sup> T-cell immunity towards cancer cellsWillemijn van der Wulp, Dennis F G Remst, Michel G D Kester, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interactionBianca Heemskerk, Tamara van Vreeswijk, Louise A Veltrop-Duits, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2017
EBV MicroRNA BART16 Suppresses Type I IFN SignalingMarjolein J G Hooykaas, Michiel van Gent, Jasper A Soppe, et al.
Journal of Virology|December 23, 2004
Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasionMaaike E Ressing, Daphne van Leeuwen, Frank A W Verreck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAPRutger D Luteijn, Hanneke Hoelen, Elisabeth Kruse, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2003
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognitionMaaike E Ressing, Daphne van Leeuwen, Frank A W Verreck, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2005
Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processingDanijela Koppers-Lalic, Eric A J Reits, Maaike E Ressing, et al.
Frontiers in Immunology|June 1, 2023
Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cellsWillemijn van der Wulp, Anna M Gram, Boris Bleijlevens, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Virology|December 17, 2010
The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus VaricellovirusMarieke C Verweij, Andrea D Lipinska, Danijela Koppers-Lalic, et al.
Plos Pathogens|March 4, 2014
Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signalingMichiel van Gent, Steven G E Braem, Annemieke de Jong, et al.
Cancer Gene Therapy|November 9, 2023
Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8<sup>+</sup> T-cell immunity towards cancer cellsWillemijn van der Wulp, Dennis F G Remst, Michel G D Kester, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interactionBianca Heemskerk, Tamara van Vreeswijk, Louise A Veltrop-Duits, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2017
EBV MicroRNA BART16 Suppresses Type I IFN SignalingMarjolein J G Hooykaas, Michiel van Gent, Jasper A Soppe, et al.
Journal of Virology|December 23, 2004
Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasionMaaike E Ressing, Daphne van Leeuwen, Frank A W Verreck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAPRutger D Luteijn, Hanneke Hoelen, Elisabeth Kruse, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2003
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognitionMaaike E Ressing, Daphne van Leeuwen, Frank A W Verreck, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2005
Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processingDanijela Koppers-Lalic, Eric A J Reits, Maaike E Ressing, et al.
Frontiers in Immunology|June 1, 2023
Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cellsWillemijn van der Wulp, Anna M Gram, Boris Bleijlevens, et al.
Pageof 6